Enfermedades Cardiovasculares
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
De Caterina R, Ammentorp B, Darius H, Le Heuzey JY, Renda G, Schilling RJ, Schliephacke T, Reimitz PE, Schmitt J, Schober C, Zamorano JL, Kirchhof P.
Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe
HEART . 100(20): 1625-1635. Nº de citas: 31
-
Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R, SIGNIFY Investigators.
Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure
NEW ENGLAND JOURNAL OF MEDICINE . 371(12): 1091-1099. Nº de citas: 385
-
Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, Hert SD, Ford I, Gonzalez-Juanatey JR, Gorenek B, Heyndrickx GR, Hoeft A, Huber K, Iung B, Kjeldsen KP, Longrois D, Lüscher TF, Pierard L, Pocock S, Price S, Roffi M, Sirnes PA, Sousa-Uva M, Voudris V, Funck-Brentano C, Zamorano JL.
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA)
EUROPEAN HEART JOURNAL . 35(35, SI): 2383-2431. Nº de citas: 1096
-
McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR.
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
NEW ENGLAND JOURNAL OF MEDICINE . 371(11): 993-1004. Nº de citas: 5327
-
del Castillo-Carnevali H, Barrios Alonso V, Zamorano Gómez JL.
Antiplatelet therapy: Resistance to traditional antiaggregation drugs and role of new antiplatelet agents
MEDICINA CLINICA . 143(5): 222-229. Nº de citas: 1
-
Franco E, Mateos A, Acebal C, Fernández-Ortiz A, Sánchez-Brunete V, García-Rubira JC, Fernández-Campos MJ, Macaya C, Ibáñez B.
Prehospital activation of cardiac catheterization teams in ST-segment elevation myocardial infarction
Revista Portuguesa de Cardiologia . 33(9): 545-553.
-
Zamorano JL, González-Gómez A, Lancellotti P.
Mitral valve anatomy: implications for transcatheter mitral valve interventions.
EuroIntervention . 10 Suppl U: .
-
Tendera M, Fox K, Ferrari R, Ford I, Greenlaw N, Abergel H, Macarie C, Tardif JC, Vardas P, Zamorano J, Gabriel Steg P.
Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry
International Journal of Cardiology . 176(1): 119-124. Nº de citas: 28
-
Kopecna D, Briongos S, Castillo H, Moreno C, Recio M, Navas P, Lobo JL, Alonso-Gomez A, Obieta-Fresnedo I, Fernández-Golfin C, Zamorano JL, Jiménez D.
Interobserver reliability of echocardiography for prognostication of normotensive patients with pulmonary embolism
Cardiovascular Ultrasound . 12: 29-29. Nº de citas: 43
-
Moreno J, Zamorano JL.
The CABANA trial
EUROPEAN HEART JOURNAL . 35(29): 1908-1909. Nº de citas: 15
-
Lázaro C, Hinojar R, Zamorano JL.
Cardiac imaging in prosthetic paravalvular leaks.
Cardiovascular Diagnosis and Therapy . 4(4): 307-313.
-
Tarín C, Fernández-Laso V, Sastre C, Madrigal-Matute J, Gómez M, Zaragoza C, Egido J, Burkly LC, Martín-Ventura JL, Blanco-Colio LM.
Tumor Necrosis Factor-Like Weak Inducer of Apoptosis or Fn14 Deficiency Reduce Elastase Perfusion-Induced Aortic Abdominal Aneurysm in Mice
Journal of the American Heart Association . 3(4): . Nº de citas: 21
-
Lavin B, Gómez M, Pello OM, Castejon B, Piedras MJ, Saura M, Zaragoza C.
Nitric Oxide Prevents Aortic Neointimal Hyperplasia by Controlling Macrophage Polarization
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY . 34(8): 1739-1739. Nº de citas: 44
-
Windecker S, Hernández-Antolín RA, Stefanini GG, Wijns W, Zamorano JL.
Management of ST-elevation myocardial infarction according to European and American guidelines
EuroIntervention . 10(S): 23-31. Nº de citas: 54
-
Todd D, Bongiorni MG, Hernandez-Madrid A, Dagres N, Sciaraffia E, Blomström-Lundqvist C.
Standards for device implantation and follow-up: personnel, equipment, and facilities: results of the European Heart Rhythm Association Survey
EUROPACE . 16(8): 1236-1239. Nº de citas: 11
-
Aicart-Ramos C, Sánchez-Ruiloba L, Gómez-Parrizas M, Zaragoza C, Iglesias T, Rodríguez-Crespo I.
Protein kinase D activity controls endothelial nitric oxide synthesis
JOURNAL OF CELL SCIENCE . 127(15): 3360-3372. Nº de citas: 11
-
Varma N, Hinojar R, D'Cruz D, Arroyo Ucar E, Indermuehle A, Peel S, Greil G, Gaddum N, Chowienczyk P, Nagel E, Botnar RM, Puntmann VO.
Coronary Vessel Wall Contrast Enhancement Imaging as a Potential Direct Marker of Coronary Involvement Integration of Findings From CAD and SLE Patients
JACC-Cardiovascular Imaging . 7(8): 762-770. Nº de citas: 46
-
Kalra PR, García-Moll X, Zamorano J, Kalra PA, Fox KM, Ford I, Ferrari R, Tardif JC, Tendera M, Greenlaw N, Steg PG.
Impact of Chronic Kidney Disease on Use of Evidence-Based Therapy in Stable Coronary Artery Disease: A Prospective Analysis of 22,272 Patients
PLoS One . 9(7): . Nº de citas: 22